Aungst BJ - Search Results

1

Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa.

Pinto DJ, Orwat MJ, Wang S, Fevig JM, Quan ML, Amparo E, Cacciola J, Rossi KA, Alexander RS, Smallwood AM, Luettgen JM, Liang L, Aungst BJ, Wright MR, Knabb RM, Wong PC, Wexler RR, Lam PY. Pinto DJ, et al. Among authors: aungst bj. J Med Chem. 2001 Feb 15;44(4):566-78. doi: 10.1021/jm000409z. J Med Chem. 2001. PMID: 11170646

2

The de novo design and synthesis of cyclic urea inhibitors of factor Xa: optimization of the S4 ligand.

Galemmo RA Jr, Wells BL, Rossi KA, Alexander RS, Dominguez C, Maduskuie TP, Stouten PF, Wright MR, Aungst BJ, Wong PC, Knabb RM, Wexler RR. Galemmo RA Jr, et al. Among authors: aungst bj. Bioorg Med Chem Lett. 2000 Feb 7;10(3):301-4. doi: 10.1016/s0960-894x(99)00688-5. Bioorg Med Chem Lett. 2000. PMID: 10698459

3

Anticoagulant activity of a peptide boronic acid thrombin inhibitor by various routes of administration in rats.

Hussain MA, Knabb R, Aungst BJ, Kettner C. Hussain MA, et al. Among authors: aungst bj. Peptides. 1991 Sep-Oct;12(5):1153-4. doi: 10.1016/0196-9781(91)90073-x. Peptides. 1991. PMID: 1800952

4

De novo design and discovery of cyclic HIV protease inhibitors capable of displacing the active-site structural water molecule.

De Lucca GV, Jadhav PK, Waltermire RE, Aungst BJ, Erickson-Viitanen S, Lam PY. De Lucca GV, et al. Among authors: aungst bj. Pharm Biotechnol. 1998;11:257-84. doi: 10.1007/0-306-47384-4_12. Pharm Biotechnol. 1998. PMID: 9760684 Review. No abstract available.

5

Formulation and food effects on the oral absorption of a poorly water soluble, highly permeable antiretroviral agent.

Aungst BJ, Nguyen NH, Taylor NJ, Bindra DS. Aungst BJ, et al. J Pharm Sci. 2002 Jun;91(6):1390-5. doi: 10.1002/jps.10120. J Pharm Sci. 2002. PMID: 12115838

6

Prodrugs for improved oral beta-estradiol bioavailability.

Hussain MA, Aungst BJ, Shefter E. Hussain MA, et al. Among authors: aungst bj. Pharm Res. 1988 Jan;5(1):44-7. doi: 10.1023/a:1015863412137. Pharm Res. 1988. PMID: 3244608

7

Prodrugs to improve the oral bioavailability of a diacidic nonpeptide angiotensin II antagonist.

Aungst BJ, Blake JA, Rogers NJ, Saitoh H, Hussain MA, Ensinger CL, Pruitt JR. Aungst BJ, et al. Pharm Res. 1995 May;12(5):763-7. doi: 10.1023/a:1016228129729. Pharm Res. 1995. PMID: 7479565

8

Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants.

Aungst BJ. Aungst BJ. Pharm Res. 1989 Mar;6(3):244-7. doi: 10.1023/a:1015921702258. Pharm Res. 1989. PMID: 2726682

9

Intestinal permeation enhancers.

Aungst BJ. Aungst BJ. J Pharm Sci. 2000 Apr;89(4):429-42. doi: 10.1002/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J. J Pharm Sci. 2000. PMID: 10737905 Review.

10

Intranasal absorption of the platelet glycoprotein IIb/IIIa receptor antagonist, DMP 755, and the effect of anesthesia on nasal bioavailability.

Hussain MA, Aungst BJ, Kapil R, Mousa SA. Hussain MA, et al. Among authors: aungst bj. J Pharm Sci. 1997 Dec;86(12):1358-60. doi: 10.1021/js970208r. J Pharm Sci. 1997. PMID: 9423145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters